| 2013 | | A formulated red ginseng extract upregulates CHOP and increases TRAIL-mediated cytotoxicity in human hepatocellular carcinoma cells. | 김유선 |
| 2007 | | A human scFv antibody against TRAIL receptor 2 induces autophagic cell death in both TRAIL-sensitive and TRAIL-resistant cancer cells. | 권명희, 최경숙 |
| 2011 | | Acrolein sensitizes human renal cancer Caki cells to TRAIL-induced apoptosis via ROS-mediated up-regulation of death receptor-5 (DR5) and down-regulation of Bcl-2. | 최경숙 |
| 2011 | | Amiodarone sensitizes human glioma cells but not astrocytes to TRAIL-induced apoptosis via CHOP-mediated DR5 upregulation. | 최경숙 |
| 2012 | | An agonistic antibody to human death receptor 4 induces apoptotic cell death in head and neck cancer cells through mitochondrial ROS generation | 김철호, 신유섭, 이복순 |
| 2003 | | Analysis of the phenotypes of Jurkat clones with different TRAIL-sensitivities. | 김형일, 장영주 |
| 2012 | | Aspirin enhances TRAIL-induced apoptosis via regulation of ERK1/2 activation in human cervical cancer cells. | 장영주 |
| 2012 | | Aurora B confers cancer cell resistance to TRAIL-induced apoptosis via phosphorylation of survivin | 최경숙 |
| 2010 | | Capsaicin sensitizes malignant glioma cells to TRAIL-mediated apoptosis via DR5 upregulation and survivin downregulation. | 최경숙 |
| 2016 | | Chloroquine enhances TRAIL-mediated apoptosis through up-regulation of DR5 by stabilization of mRNA and protein in cancer cells | 최경숙 |
| 2010 | | Compound C sensitizes Caki renal cancer cells to TRAIL-induced apoptosis through reactive oxygen species-mediated down-regulation of c-FLIPL and Mcl-1. | 최경숙 |
| 2005 | | Curcumin sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis through reactive oxygen species-mediated upregulation of death receptor 5 (DR5). | 최경숙 |
| 2006 | | Curcumin sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis through CHOP-independent DR5 upregulation. | 최경숙 |
| 2014 | | Dicoumarol sensitizes renal cell carcinoma Caki cells to TRAIL-induced apoptosis through down-regulation of Bcl-2, Mcl-1 and c-FLIP in a NQO1-independent manner. | 최경숙 |
| 2016 | | Downregulation of Nrf2 by the combination of TRAIL and Valproic acid induces apoptotic cell death of TRAIL-resistant papillary thyroid cancer cells via suppression of Bcl-xL | 김철호, 신유섭, 이복순, 한재호 |
| 2023 | | Exosomal delivery of TRAIL and miR‑335 for the treatment of hepatocellular carcinoma (Review) | 최용준 |
| 2012 | | Glucocorticoid receptor antagonist sensitizes TRAIL-induced apoptosis in renal carcinoma cells through up-regulation of DR5 and down-regulation of c-FLIP(L) and Bcl-2 | 최경숙 |
| 2005 | | Homomeric and heteromeric interactions of the extracellular domains of death receptors and death decoy receptors. | 권명희 |
| 2007 | | Inducing rigid local structure around the zinc-binding region by hydrophobic interactions enhances the homotrimerization and apoptotic activity of zinc-free TRAIL. | 권명희 |
| 2017 | | Inhibition of Cathepsin S Induces Mitochondrial ROS That Sensitizes TRAIL-Mediated Apoptosis Through p53-Mediated Downregulation of Bcl-2 and c-FLIP | 윤계순, 이영경, 최경숙 |
| 2001 | | Ionizing radiation can overcome resistance to TRAIL in TRAIL-resistant cancer cells. | 장영주 |
| 2006 | | Mithramycin A sensitizes cancer cells to TRAIL-mediated apoptosis by down-regulation of XIAP gene promoter through Sp1 sites. | 최경숙 |
| 2013 | | Monensin, a polyether ionophore antibiotic, overcomes TRAIL resistance in glioma cells via endoplasmic reticulum stress, DR5 upregulation and c-FLIP downregulation. | 임준희, 최경숙 |
| 2020 | | Non-Thermal Plasma Couples Oxidative Stress to TRAIL Sensitization through DR5 Upregulation | 이영수 |
| 2013 | | Nutlin-3, a small-molecule MDM2 inhibitor, sensitizes Caki cells to TRAIL-induced apoptosis through p53-mediated PUMA upregulation and ROS-mediated DR5 upregulation. | 최경숙 |
| 2021 | | OTUB1 knockdown promotes apoptosis in melanoma cells by upregulating TRAIL expression | 강성운, 김철호 |
| 2010 | | Overexpression of Par-4 sensitizes TRAIL-induced apoptosis via inactivation of NF-kappaB and Akt signaling pathways in renal cancer cells. | 최경숙 |
| 2011 | | Paxilline enhances TRAIL-mediated apoptosis of glioma cells via modulation of c-FLIP, survivin and DR5. | 최경숙 |
| 2007 | | Phytosphingosine in combination with TRAIL sensitizes cancer cells to TRAIL through synergistic up-regulation of DR4 and DR5. | 장영주 |
| 2020 | | Reduction in MLKL-mediated endosomal trafficking enhances the TRAIL-DR4/5 signal to increase cancer cell death | 김유선, 홍선미 |
| 2005 | | Rottlerin sensitizes glioma cells to TRAIL-induced apoptosis by inhibition of Cdc2 and the subsequent downregulation of survivin and XIAP. | 김승업, 최경숙 |
| 2013 | | Sensitization of TRAIL-induced cell death by 20(S)-ginsenoside Rg3 via CHOP-mediated DR5 upregulation in human hepatocellular carcinoma cells. | 김유선 |
| 2007 | | Silibinin sensitizes human glioma cells to TRAIL-mediated apoptosis via DR5 up-regulation and down-regulation of c-FLIP and survivin. | 최경숙 |
| 2005 | | Sodium butyrate sensitizes human glioma cells to TRAIL-mediated apoptosis through inhibition of Cdc2 and the subsequent downregulation of survivin and XIAP. | 김승업, 최경숙 |
| 2006 | | Sulforaphane sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-resistant hepatoma cells to TRAIL-induced apoptosis through reactive oxygen species-mediated up-regulation of DR5. | 김욱환, 최경숙 |
| 2012 | | The proteasome inhibitor MG132 potentiates TRAIL receptor agonist-induced apoptosis by stabilizing tBid and Bik in human head and neck squamous cell carcinoma cells | 김철호 |
| 2011 | | TRADD is critical for resistance to TRAIL-induced cell death through NF-κB activation. | 김유선 |
